FDA Approves First Drug to Treat Medical Burnout | Medpage Today

“Idongivafumab’s unique ability to target and inhibit C-suite peptides, as well the entire electronic health record (EHR) cascade, represents a quantum leap in burnout science,” Palmer explained in a statement.

“Clinical test subjects also noted a marked decrease in symptoms of Entitled Patient Pruritus (EPP) during the course of treatment. Some 87% of those treated stated they felt ready to type at a keyboard with their back to the patient; feeling a need to apply to law school, write a novel, or sell crafts on Etsy fell by a whopping 98%. This drug may truly revolutionize health care.”

https://gomerblog.com/2019/07/fda-approves-first-novel-drug-to-treat-medical-burnout/